Neurology ReviewsReanalysis of Cladribine Data Confirms and Extends the Benefits Seen in ORACLE-MSMay 26, 2016Multiple Sclerosis
Neurology ReviewsTrial Supports Further Investigation of SAGE-547 in Super-Refractory Status EpilepticusMay 26, 2016Epilepsy & Seizures
Neurology ReviewsDoes Natalizumab Benefit Patients With Secondary Progressive MS?May 26, 2016Multiple Sclerosis
Neurology ReviewsBlood Pressure Trajectories May Affect Risk of Stroke and MortalityMay 26, 2016Stroke
Clinical Neurology NewsAge, lower baseline ALC increase dimethyl fumarate lymphopenia riskMay 26, 2016Multiple Sclerosis
Clinical Neurology NewsOcrelizumab bests interferon for relapsing MS at 2 yearsMay 25, 2016Multiple Sclerosis
Clinical Neurology NewsWatchman registry provides reassuring answers on device safetyMay 25, 2016Stroke
Clinical Neurology NewsJudge says feds overstepped on ACA cost-sharing subsidiesMay 23, 2016Business of Medicine
Clinical Neurology NewsAfter 2006 recommendation, more autism diagnoses made at earlier ageMay 21, 2016Pediatrics
Clinical Neurology NewsNeurologists’ hospital revenue up almost 50% since 2012May 20, 2016Business of Medicine
Clinical Neurology NewsImproving our crystal ball: prognostication in neuroscience ICUsMay 20, 2016StrokeNeurosurgery & Trauma
Clinical Neurology NewsDiabetic foot ulcers linked to cognitive declineMay 19, 2016Alzheimer's & Cognition
Clinical Neurology NewsScreen and treat MS patients for emotional distress, depressionMay 17, 2016Multiple Sclerosis
Neurology ReviewsBlood Test Detects Concussion Up to One Week LaterMay 17, 2016Traumatic Brain Injury
